FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2514299433> ?p ?o ?g. }

• W2514299433 abstract "A phase 2 protocol was designed and implemented to assess the toxicity and efficacy of hypofractionated image guided intensity modulated radiation therapy (IG-IMRT) combined with low-dose rate 103Pd prostate seed implant for treatment of localized intermediate- and high-risk adenocarcinoma of the prostate.This is a report of an interim analysis on 24 patients enrolled on an institutional review board-approved phase 2 single-institution study of patients with intermediate- and high-risk adenocarcinoma of the prostate. The median pretreatment prostate-specific antigen level was 8.15 ng/mL. The median Gleason score was 4 + 3 = 7 (range, 3 + 4 = 7 - 4 + 4 = 8), and the median T stage was T2a. Of the 24 patients, 4 (17%) were high-risk patients as defined by the National Comprehensive Cancer Network criteria, version 2016. The treatment consisted of 2465 cGy in 493 cGy/fraction of IG-IMRT to the prostate and seminal vesicles. This was followed by a 103Pd transperineal prostate implant boost (prescribed dose to 90% of the prostate volume of 100 Gy) using intraoperative planning. Five patients received neoadjuvant, concurrent, and adjuvant androgen deprivation therapy.The median follow-up was 18 months (range, 1-42 months). The median nadir prostate-specific antigen was 0.5 ng/mL and time to nadir was 16 months. There was 1 biochemical failure associated with distant metastatic disease without local failure. Toxicity (acute or late) higher than grade 3 was not observed. There was a single instance of late grade 3 genitourinary toxicity secondary to hematuria 2 years and 7 months after radiation treatment. There were no other grade 3 gastrointestinal or genitourinary toxicities.Early results on the toxicity and efficacy of the combination of hypofractionated IG-IMRT and low-dose-rate brachytherapy boost are favorable. Longer follow-up is needed to confirm safety and effectiveness." @default.
• W2514299433 created "2016-09-16" @default.
• W2514299433 creator A5002491597 @default.
• W2514299433 creator A5015189447 @default.
• W2514299433 creator A5026657504 @default.
• W2514299433 creator A5078734526 @default.
• W2514299433 creator A5089015339 @default.
• W2514299433 date "2016-10-01" @default.
• W2514299433 modified "2023-09-24" @default.
• W2514299433 title "Hypofractionated image guided radiation therapy followed by prostate seed implant boost for men with newly diagnosed intermediate and high risk adenocarcinoma of the prostate: Preliminary results of a phase 2 prospective study" @default.
• W2514299433 cites W154575524 @default.
• W2514299433 cites W1552780421 @default.
• W2514299433 cites W1874355795 @default.
• W2514299433 cites W1969753482 @default.
• W2514299433 cites W1973462147 @default.
• W2514299433 cites W1983129876 @default.
• W2514299433 cites W1984023692 @default.
• W2514299433 cites W1987091090 @default.
• W2514299433 cites W1993558610 @default.
• W2514299433 cites W1996809772 @default.
• W2514299433 cites W2000629525 @default.
• W2514299433 cites W2002612178 @default.
• W2514299433 cites W2009446017 @default.
• W2514299433 cites W2031668223 @default.
• W2514299433 cites W2048415179 @default.
• W2514299433 cites W2049386837 @default.
• W2514299433 cites W2054527786 @default.
• W2514299433 cites W2054899405 @default.
• W2514299433 cites W2056643793 @default.
• W2514299433 cites W2061131146 @default.
• W2514299433 cites W2069735760 @default.
• W2514299433 cites W2071365490 @default.
• W2514299433 cites W2093867637 @default.
• W2514299433 cites W2094442174 @default.
• W2514299433 cites W2097532477 @default.
• W2514299433 cites W2099589368 @default.
• W2514299433 cites W2100214328 @default.
• W2514299433 cites W2104631398 @default.
• W2514299433 cites W2108134400 @default.
• W2514299433 cites W2111180711 @default.
• W2514299433 cites W2114221591 @default.
• W2514299433 cites W2118044567 @default.
• W2514299433 cites W2123284539 @default.
• W2514299433 cites W2133937721 @default.
• W2514299433 cites W2143221381 @default.
• W2514299433 cites W2144550734 @default.
• W2514299433 cites W2145201478 @default.
• W2514299433 cites W2153544369 @default.
• W2514299433 cites W2156516389 @default.
• W2514299433 cites W2157634805 @default.
• W2514299433 cites W2164748078 @default.
• W2514299433 cites W2171127338 @default.
• W2514299433 cites W2224702980 @default.
• W2514299433 cites W2417809401 @default.
• W2514299433 cites W92720502 @default.
• W2514299433 doi "https://doi.org/10.1016/j.adro.2016.08.005" @default.
• W2514299433 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5514232" @default.
• W2514299433 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28740903" @default.
• W2514299433 hasPublicationYear "2016" @default.
• W2514299433 type Work @default.
• W2514299433 sameAs 2514299433 @default.
• W2514299433 citedByCount "0" @default.
• W2514299433 crossrefType "journal-article" @default.
• W2514299433 hasAuthorship W2514299433A5002491597 @default.
• W2514299433 hasAuthorship W2514299433A5015189447 @default.
• W2514299433 hasAuthorship W2514299433A5026657504 @default.
• W2514299433 hasAuthorship W2514299433A5078734526 @default.
• W2514299433 hasAuthorship W2514299433A5089015339 @default.
• W2514299433 hasBestOaLocation W25142994331 @default.
• W2514299433 hasConcept C121608353 @default.
• W2514299433 hasConcept C126322002 @default.
• W2514299433 hasConcept C126894567 @default.
• W2514299433 hasConcept C133507102 @default.
• W2514299433 hasConcept C141071460 @default.
• W2514299433 hasConcept C143998085 @default.
• W2514299433 hasConcept C2776235491 @default.
• W2514299433 hasConcept C2777416452 @default.
• W2514299433 hasConcept C2777899217 @default.
• W2514299433 hasConcept C2778311097 @default.
• W2514299433 hasConcept C2780192828 @default.
• W2514299433 hasConcept C2781406297 @default.
• W2514299433 hasConcept C2781411149 @default.
• W2514299433 hasConcept C509974204 @default.
• W2514299433 hasConcept C71924100 @default.
• W2514299433 hasConceptScore W2514299433C121608353 @default.
• W2514299433 hasConceptScore W2514299433C126322002 @default.
• W2514299433 hasConceptScore W2514299433C126894567 @default.
• W2514299433 hasConceptScore W2514299433C133507102 @default.
• W2514299433 hasConceptScore W2514299433C141071460 @default.
• W2514299433 hasConceptScore W2514299433C143998085 @default.
• W2514299433 hasConceptScore W2514299433C2776235491 @default.
• W2514299433 hasConceptScore W2514299433C2777416452 @default.
• W2514299433 hasConceptScore W2514299433C2777899217 @default.
• W2514299433 hasConceptScore W2514299433C2778311097 @default.
• W2514299433 hasConceptScore W2514299433C2780192828 @default.
• W2514299433 hasConceptScore W2514299433C2781406297 @default.
• W2514299433 hasConceptScore W2514299433C2781411149 @default.
• W2514299433 hasConceptScore W2514299433C509974204 @default.
• W2514299433 hasConceptScore W2514299433C71924100 @default.
• W2514299433 hasLocation W25142994331 @default.

• next